A tragic RSV vaccine trial in the 1960s set the field back for decades. Here’s how scientists finally made breakthroughs in ...

Respiratory syncytial virus (RSV) continues to affect infants and older and immunocompromised people around the world. These ...

RSV vaccines will be available for high-risk residents by early October, including all adults aged 75 and older. Eligible residents should get their RSV dose as early as possible to get protection ...

Health experts at NHS England have urged eligible pregnant women to get vaccinated against respiratory syncytial virus (RSV) ahead of winter to protect their newborns. Australia experienced its ...

An Indigenous public health expert, she creates powerful narratives by merging rigorous research with cultural insight—and ...

With respiratory syncytial virus (RSV) hospitalizations surging nationwide, parents and caregivers face increasing pressure to distinguish between ordinary sniffles and potentially serious infections.

When a new immunization to protect newborns from respiratory syncytial virus (RSV) became available in late 2023, pediatricians at Temple University Hospital noted an unusually strong early interest ...

Mid-September to late October is the optimal window for people to receive the updated vaccinations to protect against severe ...

Respiratory Syncytial Virus or RSV is one of the most common respiratory viruses circulating today. Often thought of as only being dangerous to babies and toddlers due to how often child-related RSV ...

Respiratory illnesses are on the rise throughout the United States, and health officials are warning of a tripledemic. They recommend taking action to mitigate the spread of airborne illnesses. Here's ...